A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of Cardiolite Myocardial Perfusion Imaging in Pediatric Subjects with Kawaski Disease

  • Vranicar, Mark (PI)
  • Borgia, Lisa (CoI)
  • Bruns, Reva (CoI)
  • Chamblin, Lisa (CoI)
  • Holbrook, Kathryn (CoI)
  • Kaenzig, Janet (CoI)
  • Townsend, Janet (CoI)

Grants and Contracts Details

Effective start/end date3/27/063/27/10


  • Bristol Myers Squibb Company: $19,588.00